[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":30903000.0,"InvestmentIncomeAmortizationOfDiscount_1_Q1_USD":44000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q1_USD":0.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q1_USD":106000.0,"HeldToMaturitySecurities_0_Q1_USD":26284000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1_Q1_USD":-257000.0,"DeferredRevenueNoncurrent_0_Q1_USD":724000.0,"ConstructionContractCostProgressPaymentOffset_0_Q1_USD":20300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-60584000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":78300000.0,"AmortizationOfLeaseIncentives_1_Q1_USD":54000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":171000.0,"AmortizationOfFinancingCosts_1_Q1_USD":231000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":11068000.0,"OtherLiabilitiesCurrent_0_Q1_USD":29245000.0,"ShortTermInvestments_0_Q1_USD":26284000.0,"HeldToMaturitySecuritiesFairValue_0_Q1_USD":26390000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":53303000.0,"OtherAssetsCurrent_0_Q1_USD":1944000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-18898000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":1057000.0,"TreasuryStockValue_0_Q1_USD":234000.0,"TreasuryStockShares_0_Q1_shares":41309.0,"LongTermNotesPayable_0_Q1_USD":0.0,"LeaseCost_1_Q1_USD":507000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":-1567000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":19540000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1796000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1_Q1_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_1_Q1_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1_Q1_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_0_Q1_USD":847054000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2001000.0,"RestrictedStockExpense_1_Q1_USD":7120000.0,"RestrictedCashNoncurrent_0_Q1_USD":1252000.0,"RestrictedCashAndInvestments_0_Q1_USD":1300000.0,"RestrictedCash_0_Q1_USD":1252000.0,"OtherResearchAndDevelopmentExpense_1_Q1_USD":34043000.0,"OtherLongTermDebt_0_Q1_USD":30000000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":9294000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":10159000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1602000.0,"OperatingLeaseLiability_0_Q1_USD":11761000.0,"OperatingLeaseCost_1_Q1_USD":507000.0,"NotesPayableFairValueDisclosure_0_Q1_USD":171000.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":4146000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":7779000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1416000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1889000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1911000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1913000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":10615000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q1_shares":147058.0,"IncreaseDecreaseInInterestPayableNet_1_Q1_USD":-832000.0,"OtherGeneralAndAdministrativeExpense_1_Q1_USD":5172000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":105461892.0,"Revenues_1_Q1_USD":38000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-752332000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":320000.0,"ProfitLoss_1_Q1_USD":-51116000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":68000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-62115000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":1450000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":81000.0,"LiabilitiesCurrent_0_Q1_USD":63118000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":101849000.0,"Liabilities_0_Q1_USD":103202000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":14261000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.48,"Depreciation_1_Q1_USD":30000.0,"CommonStockValue_0_Q1_USD":110000.0,"CommonStockSharesOutstanding_0_Q1_shares":110167984.0,"CommonStockSharesIssued_0_Q1_shares":110209293.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":52051000.0,"AssetsCurrent_0_Q1_USD":88016000.0,"Assets_0_Q1_USD":101849000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8579266.0,"AdditionalPaidInCapital_0_Q1_USD":751103000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-38000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInAccruedInterestReceivableNet_1_Q1_USD":-40000.0,"NotesPayable_0_Q1_USD":171000.0,"StockOptionPlanExpense_1_Q1_USD":3948000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":28026.0,"ProceedsFromWarrantExercises_1_Q1_USD":81000.0,"NonoperatingIncomeExpense_1_Q1_USD":-871000.0,"LongTermDebtNoncurrent_0_Q1_USD":29201000.0,"LongTermDebt_0_Q1_USD":29201000.0,"Goodwill_0_Q1_USD":799000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":171000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-1353000.0,"DeferredCompensationLiabilityCurrent_0_Q1_USD":1368000.0,"OtherIncome_1_Q1_USD":330000.0,"Cash_0_Q1_USD":47905000.0,"ShareBasedCompensation_1_Q1_USD":11068000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":36022000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-50245000.0,"OperatingExpenses_1_Q1_USD":50283000.0,"NotesPayableCurrent_0_Q1_USD":171000.0,"InterestPaidNet_1_Q1_USD":777000.0,"InterestExpense_1_Q1_USD":1201000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-1967000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":1774000.0,"Ticker":"TGTX","CIK":"1001316","name":"TG THERAPEUTICS, INC.","OfficialName":"TG Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1036853809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]